Targeting YES1 enhances the efficacy of chemotherapy, targeted therapy and onco-immunotherapy is a research paper published in Cellular Signalling (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →University of Science and Technology of China
Grant: ZD-YG-202413
Department of Science and Technology of Liaoning Province
Grant: 2020-MS-225
Hebei Provincial Natural Science Foundation
Grant: H2023209001
National Cancer Institute
Grant: P30CA013330
MeSH Terms
Keywords